not tagged
not tagged
['pivotal', 'rectal']
asco 2022: 100% complete response rate in mmrd locally advanced rectal cancer seen in pivotal immunoablative neoadjuvant immunotherapy clinical trial 
Senior Specialist in Public Health & Health Administration
M.D, MHA & MPH